BX Swiss TOP 30 CHF
1.228,04
PKT
-12,73
PKT
-1,03
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
30.05.18 | Nestlé Neutral | UBS AG | |
30.05.18 | UBS Outperform | Credit Suisse Group | |
30.05.18 | Zurich Insurance Hold | Jefferies & Company Inc. | |
30.05.18 | Roche Hold | Deutsche Bank AG | |
29.05.18 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
29.05.18 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
29.05.18 | Roche overweight | JP Morgan Chase & Co. | |
29.05.18 | Swiss Re Sell | UBS AG | |
29.05.18 | Roche buy | Baader Bank | |
29.05.18 | Roche buy | Jefferies & Company Inc. | |
29.05.18 | Novartis Hold | HSBC | |
28.05.18 | Swiss Re buy | Baader Bank | |
25.05.18 | Novartis Neutral | Credit Suisse Group | |
25.05.18 | Zurich Insurance Hold | Deutsche Bank AG | |
25.05.18 | Swiss Re buy | Deutsche Bank AG | |
25.05.18 | Swiss Re overweight | Barclays Capital | |
25.05.18 | Roche Underperform | Credit Suisse Group | |
23.05.18 | Givaudan buy | Baader Bank | |
23.05.18 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
23.05.18 | Roche overweight | Barclays Capital | |
23.05.18 | Holcim Neutral | JP Morgan Chase & Co. | |
22.05.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
22.05.18 | Roche Hold | Deutsche Bank AG | |
22.05.18 | Roche buy | Jefferies & Company Inc. | |
22.05.18 | UBS Neutral | Goldman Sachs Group Inc. | |
22.05.18 | Novartis Underweight | Barclays Capital | |
22.05.18 | Roche Neutral | Citigroup Corp. | |
22.05.18 | UBS overweight | JP Morgan Chase & Co. | |
22.05.18 | Roche overweight | JP Morgan Chase & Co. | |
22.05.18 | UBS overweight | JP Morgan Chase & Co. | |
22.05.18 | UBS buy | Goldman Sachs Group Inc. | |
18.05.18 | Nestlé overweight | Morgan Stanley | |
18.05.18 | Roche Neutral | UBS AG | |
18.05.18 | UBS buy | Citigroup Corp. | |
18.05.18 | UBS buy | Citigroup Corp. | |
17.05.18 | Novartis Hold | Deutsche Bank AG | |
17.05.18 | Holcim Outperform | Bernstein Research | |
17.05.18 | Novartis Neutral | JP Morgan Chase & Co. | |
17.05.18 | Roche overweight | JP Morgan Chase & Co. | |
16.05.18 | Zurich Insurance buy | Goldman Sachs Group Inc. |